Contributors


Richard Nares

Latest:

For My Son

A father recounts how LAF and advocacy helped him move past the grief of his son's death from leukemia.


Jeanne Erdmann

Latest:

On Guard: Gauging Aggressiveness of Prostate Cancer Aids Decision Making

New ways to find prostate cancer and gauge its aggressiveness help patients make better choices.


Patrick Dempsey

Latest:

A Word from Patrick Dempsey During National Ovarian Cancer Awareness Month

Patrick Dempsey discusses National Ovarian Cancer Awareness Month.


Josie Leavitt

Latest:

Suspending Judgement During Cancer Treatment

Want to support someone during cancer treatment? Offer your ear, not your opinion.


Maureen Salamon

Latest:

Scanning the Horizon: Advances in Radiation Treatment for Prostate Cancer

New advances in radiation treatment enable higher doses with less damage to nearby tissue.


Axel Hoos, M.D., Ph.D.

Latest:

Axel Hoos on the ATOM Initiative

Axel Hoos, M.D., Ph.D. of GlaxoSmithKline discusses the ATOM Initiative.


Roberto Benzo, MD, MS

Latest:

Adding Mindfulness: Innovation for an Optimal Preoperative Rehabilitation Before Lung Cancer Resection

A recent study looked at a two-week preoperative intervention for lung cancer resection that included an intervention intended for emotional balance: mindfulness.


Barbara Abernathy, Ph.D.

Latest:

Finding Your Fight Mode After a Cancer Diagnosis

After finding out she had an MPN, Barbara Abernathy, Ph.D., like many other people, felt numb. But then it was time to find her fight mode.


Dan Shapiro, PhD

Latest:

Coming Back Out of the Closet

When healing comes from quiet corners, soft words and family moments.


Morhaf Al Achkar, M.D., PH.D

Latest:

Living With Lung Cancer Amid Coronavirus

As coronavirus fears escalate, a physician with stage 4 lung cancer reflects on protecting personal health and aiding the global community.


Steve Pake

Latest:

The Value of Testicular Self-Exams and Early Detection from the Survivorship Perspective

There’s been some debate in recent years about the true value and effectiveness of certain types of cancer screenings. This is, of course, a perfectly reasonable thing to be doing both in the name of advancing medical science, and especially in an environment where there's so much downward pressure on the costs of healthcare.


Corine Mogenis

Latest:

Finding Life's Purpose in the Craziest Circumstances

How much better can I help people now that I have been through it myself?


Meir Rinde

Latest:

Exploring Genetic Differences in Men's Breast Cancer

The genetic differences that distinguish men’s breast cancers may lead to new diagnosis and treatment options.


Sr. Rosemary Donley, Ph.D., APRN, FAAN, Duquesne University

Latest:

Improving Care Against All Odds

An Extraordinary Healer essay honoring JOAN SUCH LOCKHART, PH.D., RN, AOCN, CNE, ANEF, FAAN [DUQUESNE UNIVERSITY SCHOOL OF NURSING, PITTSBURGH, PENNSYLVANIA]


Lacey Marlow

Latest:

Managing Thrombocytopenia

Certain types of cancer treatments can result in the body having too few platelets, a condition called thrombocytopenia, which can increase the risk of bleeding.


Steve Rubin

Latest:

A Lesson About Mindset I Learned Overcoming a Less than 10% Survival Rate

Looking back at my experience with osteosarcoma, I realized that managing the mental game was half the battle, especially with so much negativity.


Michael J. Mauro

Latest:

Michael J. Mauro on Questions From Patients With CML

Michael J. Mauro, provides an overview of some of the questions he hears from patients with chronic myeloid leukemia (CML).


Ted James, MD

Latest:

Diet and Lifestyle Influences in Breast Cancer

Reduce breast cancer risk through diet and lifestyle.


Kevin Cropp

Latest:

A Beautiful Day: The Story of a Son's Loss

Remembering and honoring his mother’s memory, a son recalls one of her last days.



Kristinna Abalos

Latest:

In Sickness and in Health

If your chair was cold, I knew you were two floors down in the NICU cradling your only child – the only one I’d be able to give you – making sure his IV and nutrition lines were also connected and beeping lively and skipping at the same beat as mine.


Diana M. Martin

Latest:

Cancer Caregivers Need Extra Support During and After the COVID-19 Pandemic

Having been a caregiver to my late husband who died from cancer, I know first-hand the difficulties of caregiving — not to mention what it must be like for those trying to do it during a worldwide pandemic.


Andy Himes

Latest:

Connecting With The Heart

MY WIFE passed away on Feb. 2, 2014, from a six-year battle with cancer. It is my honor to nominate one angel in particular who, in the end, became much more than a nurse to my wife.


Rosemary E. Manbachi, CRNP

Latest:

My Personal Cancer Warrior

An Extraordinary Healer essay honoring Carol Mallon, RN, MS, OCN [ Penn State Hershey Medical Center Cancer Institute in Hershey, Pennsylvania ]


Mary Barranco

Latest:

Tips from a Working Caregiver

Steps for a management plan for the working caregiver.


Larinda Conrad

Latest:

My Extraordinary Healer Before and After Cancer Treatment

An Extraordinary Healer essay honoring Debbie Cherry, LPN [ St. Jude Children's Research Hospital in Memphis, Tennessee ]


Jeannette Moninger

Latest:

BTK Inhibitors Offer a Revolutionary Treatment of Relapsed CLL/SLL

Bruton tyrosine kinase inhibitors have changed the space for treating patients with CLL or SLL, with more on the way to potentially address drug resistance.


Pancreatic Cancer Action Network

Latest:

PANCREATIC CANCER ACTION NETWORK ANNOUNCES GROUNDBREAKING CLINICAL TRIAL PLATFORM TRANSFORMING DEVELOPMENT OF TREATMENT OPTIONS FOR WORLD’S TOUGHEST CANCER

Adaptive Clinical Trial Design Is More Cost Effective, Patient-Centric and Allows for Faster Learning Than Standard Trials


Dave McNeely

Latest:

Shunning the Sidelines

Cheers to Elizabeth Edwards, who isn't letting cancer stop her.


Darcy Lewis

Latest:

Study Shows Zejula's Benefit in Treating Ovarian Cancer

Superior progression-free survival (PFS) was seen in patients with ovarian cancer who previously had a partial response (PR) to platinum-based therapy when they took Zejula (niraparib). This response was seen in patients with or without germline BRCA mutations, according to data from the ENGOT-OV16/NOVA trial presented at the 2017 ASCO Annual Meeting.